```html

Thrombus (Blood Clot)

What is Thrombus (Blood Clot)?

A thrombus is a mass of coagulated blood that forms within a blood vessel (artery or vein) or inside the heart. Unlike a normal clot that stops bleeding after an injury, a thrombus develops when the clotting system is activated inappropriately and can obstruct blood flow, depriving tissues of oxygen and nutrients. If a thrombus breaks loose and travels through the bloodstream, it becomes an embolus, which can lodge in distant vessels and cause life‑threatening events such as stroke or pulmonary embolism.

Thrombus formation is the result of three main physiologic processes, often referred to as Virchow’s triad:

• Endothelial injury – damage to the inner lining of a vessel.
• Stasis of blood flow – slowed or turbulent flow that allows clotting factors to accumulate.
• Hypercoagulability – genetic or acquired conditions that increase the tendency of blood to clot.

Understanding these mechanisms helps clinicians both diagnose a thrombus and target preventive strategies.

Common Causes

Below are the most frequently encountered conditions that can lead to thrombus formation. Each item may involve one or more components of Virchow’s triad.

• Deep vein thrombosis (DVT) – clot in a deep leg or pelvic vein, often after prolonged immobility.
• Cardiovascular disease – atherosclerotic plaque rupture can trigger arterial clotting.
• Atrial fibrillation – irregular heart rhythm creates stasis in the atria, especially the left atrial appendage.
• Recent surgery or trauma – tissue injury and postoperative immobility increase clot risk.
• Cancer and chemotherapy – malignancy produces pro‑coagulant substances; some drugs are also thrombogenic.
• Inherited thrombophilias – Factor V Leiden, prothrombin G20210A mutation, protein C/S deficiency.
• Prenatal and postpartum period – hormonal changes and venous compression by the uterus.
• Obesity and sedentary lifestyle – excess adipose tissue raises inflammatory markers; inactivity leads to stasis.
• Hormone therapy – oral contraceptives or estrogen replacement increase clotting factor levels.
• Chronic inflammatory diseases – rheumatoid arthritis, inflammatory bowel disease, and lupus raise clot risk.

Associated Symptoms

Symptoms depend on the clot’s location, size, and whether it obstructs blood flow partially or completely.

• Leg or arm swelling – often unilateral, accompanied by a feeling of heaviness.
• Pain or cramping – may worsen when standing or walking (e.g., calf pain in DVT).
• Redness or warmth over the affected area.
• Shortness of breath, chest pain, or rapid heartbeat – classic signs of a pulmonary embolism.
• Neurological deficits – sudden weakness, numbness, difficulty speaking, or visual changes suggest a cerebral embolus or stroke.
• Abdominal pain – can indicate mesenteric ischemia from an arterial clot.
• Fever – low‑grade fever may accompany extensive thrombosis or infection of the clot (septic thrombophlebitis).

Many people experience only mild discomfort, which is why a high index of suspicion is essential, especially after surgery, long‑haul travel, or if risk factors are present.

When to See a Doctor

Prompt medical evaluation can prevent serious complications. Seek care if you notice any of the following:

• Persistent swelling or pain in one leg that does not improve within 24 hours.
• Sudden, sharp chest pain that worsens with deep breathing.
• Unexplained shortness of breath or a feeling of “air hunger.”
• Sudden weakness, numbness, or slurred speech.
• Visible discoloration (bluish or reddish) of a limb.
• Fever or chills with a painful, swollen vein.
• Any new or worsening symptoms after recent surgery, trauma, or prolonged immobility.

If you belong to a high‑risk group (e.g., known thrombophilia, active cancer, recent major surgery), consider contacting your healthcare provider even for milder symptoms.

Diagnosis

Doctors combine a thorough history, physical examination, and targeted tests to confirm a thrombus.

Laboratory Tests

• D‑dimer – a breakdown product of fibrin; elevated levels suggest recent clot formation but are non‑specific.
• Complete blood count (CBC) and metabolic panel – assess overall health and rule out infection.
• Coagulation studies – PT/INR, aPTT, and specific assays for thrombophilia when indicated.

Imaging Studies

• Compression ultrasonography – first‑line for suspected DVT; uses sound waves to visualize vein patency.
• CT pulmonary angiography (CTPA) – gold standard for detecting pulmonary embolism.
• Magnetic resonance venography (MRV) or arterial angiography – used for deep pelvic or cerebral vessels.
• Echocardiography – assesses cardiac thrombi, especially in atrial fibrillation or after myocardial infarction.

Risk‑assessment Scores

Tools such as the Wells score or the PADUA prediction model help clinicians estimate pre‑test probability and decide on further testing.

Treatment Options

Treatment goals are to stop clot growth, reduce the risk of embolization, and prevent recurrence. Management depends on clot location, severity, patient comorbidities, and bleeding risk.

Anticoagulant Medications

• Heparin (unfractionated or low‑molecular‑weight) – rapid onset; often used in hospital settings.
• Direct oral anticoagulants (DOACs) – apixaban, rivaroxaban, edoxaban, dabigatran; convenient oral dosing with fewer monitoring requirements.
• Vitamin K antagonists (warfarin) – used when DOACs are contraindicated; requires INR monitoring.

Typical duration ranges from 3 months (provoked clot) to indefinite (unprovoked or high‑risk thrombophilia).

Thrombolytic Therapy

In massive pulmonary embolism, acute limb ischemia, or life‑threatening arterial occlusion, clot‑dissolving drugs (e.g., alteplase) may be administered. Risks include serious bleeding, so use is limited to severe cases.

Mechanical Interventions

• Catheter‑directed thrombolysis or thrombectomy – minimally invasive removal of clot.
• Inferior vena cava (IVC) filter – placed when anticoagulation is contraindicated; catches emboli traveling from the legs to the lungs.
• Angioplasty and stenting – for arterial clots causing critical limb ischemia.

Supportive & Home Measures

• Elevate the affected limb and use compression stockings (30‑40 mmHg) after DVT to reduce swelling and prevent post‑thrombotic syndrome.
• Encourage gentle ambulation as soon as safely possible; movement promotes venous return.
• Stay hydrated – dehydration increases blood viscosity.
• Manage pain with acetaminophen or NSAIDs as tolerated (avoid NSAIDs if on anticoagulants unless advised).

Prevention Tips

Many thrombi are preventable with lifestyle modifications and targeted medical strategies.

• Maintain regular activity – aim for at least 150 minutes of moderate‑intensity aerobic exercise per week.
• Move during long travels – stand, walk the aisle, or do calf‑pump exercises every 1–2 hours.
• Use compression stockings for high‑risk situations (post‑surgery, long‑haul flights).
• Control weight – obesity is a strong independent risk factor.
• Quit smoking – tobacco damages vessel walls and promotes hypercoagulability.
• Manage chronic conditions – keep diabetes, hypertension, and cholesterol in target range.
• Follow prophylactic anticoagulation protocols when recommended (e.g., after orthopedic surgery).
• Stay hydrated – especially during hot weather or when ill with fever.

Emergency Warning Signs

Key Take‑Home Points

• Thrombus formation is a complex process involving vessel injury, slowed flow, and a hyper‑coagulable state.
• Common triggers include prolonged immobility, surgery, cancer, atrial fibrillation, and inherited clotting disorders.
• Symptoms vary widely; leg swelling, chest pain, and neurological deficits are red flags.
• Early diagnosis with ultrasound, CT angiography, or echocardiography dramatically reduces complications.
• Anticoagulants are the cornerstone of treatment; thrombolytics and mechanical removal are reserved for severe cases.
• Prevention hinges on mobility, weight control, hydration, and, when indicated, prophylactic medication.
• Seek emergency care for any sudden, severe symptoms that could signal an embolism.

---

Sources: Mayo Clinic, CDC, National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, New England Journal of Medicine, Journal of Thrombosis and Haemostasis.

```